Enrique Velazquez Villarreal/cancerletter.com
May 30, 2025, 20:23
Enrique Velazquez Villarreal on Joining Amplity Discussion on AI and Cancer at ASCO 2025
Enrique Velazquez Villarreal, Assistant Professor at City of Hope Cancer Center, shared a post on LinkedIn by Oncology Practice Management, adding:
“Excited to announce that I’ll be joining the Amplity Booth this weekend at the American Society of Clinical Oncology (ASCO25) Annual Meeting to discuss one of the most important topics in modern medicine: Artificial Intelligence and Cancer.
I’ll be sharing the innovative research underway at the Velazquez Villarreal Lab Department of Integrative Translational Sciences City of Hope, where we are advancing the intersection of AI and colorectal cancer multi Omics to drive impactful discoveries in Precision Oncology.
Our lab’s work will be featured at ASCO, showcasing AI agents and integration of clinical, genomic, and social determinants of health (SDOH) data to enable molecular pathway-level insights and support targeted therapy development.
Thank you to Amplity for the kind invitation – looking forward to a great conversation and connecting with colleagues driving innovation in cancer research.”
Quoting Oncology Practice Management‘s post:
“ASCO 2025 will be here in less than one week! Will you be joining us for our live interview series “Voices from ASCO: Conversations in Oncology”? We’ll be chatting with multiple oncology experts, researchers, and innovators about the future of cancer care. Stay tuned for previews of our speakers, and stop by the Amplity Booth (35157) to see the full schedule and to listen in live!
Enrique Velazquez Villarreal, MD, PhD, MPH, is a physician-scientist at City of Hope, specializing in cancer prevention, public health, and translational research. With expertise in medicine, molecular biology, and public health, he focuses on bridging research and clinical care to improve outcomes and reduce health disparities.
Passionate about health equity, he develops innovative cancer prevention strategies, conducts research on cancer’s molecular mechanisms, and leads public health initiatives to address barriers to care in underserved communities, driving advancements in cancer care and prevention globally.”
Read more on AI and Cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 30, 2025, 20:19
May 30, 2025, 19:00